Shuai Xing

Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis.

Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis.

Journal: Precision clinical medicine

Published: March 02, 2024

Development and validation of a three-dimensional deep learning-based system for assessing bowel preparation on colonoscopy video.

Development and validation of a three-dimensional deep learning-based system for assessing bowel preparation on colonoscopy video.

Journal: Frontiers in medicine

Published: September 18, 2023

Development of a Convolutional Neural Network-Based Colonoscopy Image Assessment Model for Differentiating Crohn's Disease and Ulcerative Colitis.

Development of a Convolutional Neural Network-Based Colonoscopy Image Assessment Model for Differentiating Crohn's Disease and Ulcerative Colitis.

Journal: Frontiers in medicine

Published: October 05, 2021

Modulating the conformation of the TIR domain by a neoteric MyD88 inhibitor leads to the separation of GVHD from GVT.

Modulating the conformation of the TIR domain by a neoteric MyD88 inhibitor leads to the separation of GVHD from GVT.

Journal: Leukemia & lymphoma

Published: December 04, 2018

A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-β1-Induced EMT in Vivo and in Vitro.

A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-β1-Induced EMT in Vivo and in Vitro.

Journal: Kidney & blood pressure research

Published: December 07, 2017

Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice.

Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice.

Journal: Metabolism: clinical and experimental

Published: December 28, 2015

Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro.

Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro.

Journal: Scientific reports

Published: October 06, 2015

The Wnt11 Signaling Pathway in Potential Cellular EMT and Osteochondral Differentiation Progression in Nephrolithiasis Formation.

The Wnt11 Signaling Pathway in Potential Cellular EMT and Osteochondral Differentiation Progression in Nephrolithiasis Formation.

Journal: International journal of molecular sciences

Published: April 30, 2015

Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.

Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.

Journal: Journal of the National Cancer Institute

Published: November 21, 2014

Chronic hepatitis virus infection increases the risk of pancreatic cancer: a meta-analysis.

Chronic hepatitis virus infection increases the risk of pancreatic cancer: a meta-analysis.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: December 11, 2013

Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation--a meta-analysis.

Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation--a meta-analysis.

Journal: Clinical biochemistry

Published: September 28, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026